Women's Cancer Research Foundation
Common Analgesics and Ovarian Cancer Survival: The Ovarian Cancer Prognosis and Lifestyle
Updated: May 3
Ovarian cancer (OC) is a silent killer that often goes undetected until it reaches advanced stages. Sadly, most women with OC are diagnosed with advanced-stage disease, which often results in a poor prognosis. Even after primary treatment (surgery and chemotherapy), women with OC are still at risk of disease recurrence.
However, a recent study conducted in Australia has shed some light on a potential new treatment option for women with OC. The study evaluated the association between the use of nonsteroidal anti-inflammatory drugs (NSAIDs), including regular and low-dose aspirin, and 5-year cancer-specific survival after an OC diagnosis. The population-based cohort included 958 Australian women with OC.
Even after primary treatment (surgery and chemotherapy), women with OC are still at risk of disease recurrence.
The study found that women who frequently used NSAIDs (≥4 d/wk) had better survival rates compared to non-users and infrequent users. The survival benefit was similar for both new and continuous users of aspirin and non-aspirin NSAIDs. These differences translated into a 2.5-month increase in mean survival.
The results of this study are promising and suggest that NSAID use might improve OC survival. However, it is important to note that the study did not prove causation and that more research is needed to confirm these findings. Nonetheless, this study provides hope for women with Ovarian Cancer suggests that NSAIDs may be a useful addition to current treatment options.
It is also important to note that NSAIDs have potential side effects, such as gastrointestinal bleeding and cardiovascular events, which need to be carefully considered. Therefore, women with OC should always consult with their healthcare provider before starting any new treatment.
This study provides hope for women with OC and suggests that NSAIDs may be a useful addition to current treatment options.
In conclusion, the findings of this study are encouraging and highlight the potential benefits of NSAID use for women with OC. Further research is needed to confirm these findings, but this study provides hope for women with this deadly disease. It is important for women with OC to work closely with their healthcare provider to determine the best treatment options for them.
About Women’s Cancer Research Foundation:
The Women’s Cancer Research Foundation (WCRF) is one of the most active research organizations in the nation. We are dedicated to studying and evaluating novel treatments for women afflicted with breast, ovarian, endometrial, and cervical cancers. The WCRF persistently endeavors to make a difference in women’s lives by offering them hope, strength, and progress.
Women’s Cancer Research Foundation (WCRF)
Laguna Beach, CA 92651
PH: (949) 642-5165
Follow Us On Social Media:
#ovariancancer #NSAIDS #chemotherapy #cancerresearch #lowdoseaspirin